News
Freshfields Advises Agilent on Its Sale of Resolution Bioscience
Freshfields advises Agilent Technologies, a global leader in analytical and clinical laboratory technologies, on its agreement to sell Resolution Bioscience, a company that develops and commercializes next-generation sequencing-based precision oncology solutions, to Exact Sciences Corporation. Agilent acquired Resolution Bioscience in 2021 in a transaction on which Freshfields also advised.
Further details of the transaction are available here.
The Freshfields deal team included Global Transactions partner Jonathan Zhou and senior associate Max Sanders, Intellectual Property partner Mena Kaplan, senior associate Marissa Yu and associate Jennifer Lei, Life Sciences partner Vinita Kailasanath, People and Rewards partner Sarah Ghulamhussain, and paralegals Cavika Prashad and Michael Tozzi.
About Freshfields Bruckhaus Deringer LLP
Freshfields Bruckhaus Deringer is a global law firm with a long-standing track record of successfully supporting the world's leading national and multinational corporations, financial institutions and governments on groundbreaking and business-critical mandates. Our 2,800-plus lawyers deliver results worldwide through our own offices and alongside leading local firms. Our commitment, local and multinational expertise, and business know-how means our clients rely on us when it matters most.
Freshfields is ranked by Chambers Global in Band 1 across the six areas of antitrust, corporate/M&A, litigation, international arbitration, tax, and public international law. For more information visit Freshfields.us.
